Prophylactic Vaccination with Adjuvant Monophosphoryl Lipid A Prevents Th2-Mediated Murine Asthmatic Responses

References

• Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. Global variation in the prevalence and severity of asthma symptoms: Phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64(6):476–483.
   PubMed Web of Science ®Google Scholar
• Zock JP, Heinrich J, Jarvis D, Verlato G, Norback D, Plana E, Sunyer J, Chinn S, Olivieri M, Soon A, Villani S, Ponzio M, Dahlman-Hoglund A, Svanes C, Luczynska C. Distribution and determinants of house dust mite allergens in Europe: The European community respiratory health survey II. J Allergy Clin Immunol 2006; 118(3):682–690.
   PubMed Web of Science ®Google Scholar
• Broide DH. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 2001; 108(2 Suppl):S65–S71.
   PubMed Web of Science ®Google Scholar
• Lee YC, Lee KH, Lee HB, Rhee YK. Serum levels of interleukins (IL)-4, IL-5, IL-13, and interferon-gamma in acute asthma. J Asthma 2001; 38(8):665–671.
   PubMed Web of Science ®Google Scholar
• Larche M. Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr Opin Immunol 2006; 18(6):745–750.
   PubMed Web of Science ®Google Scholar
• Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 2008; 8(3):169–182.
   PubMed Web of Science ®Google Scholar
• Montealegre F, Meyer B, Chardon D, Vargas W, Zavala D, Hart B, Bayona M. Comparative prevalence of sensitization to common animal, plant and mould allergens in subjects with asthma, or atopic dermatitis and/or allergic rhinitis living in a tropical environment. Clin Exp Allergy 2004; 34(1):51–58.
   PubMed Web of Science ®Google Scholar
• Sun HL, Lue KH. Household distribution of house dust mite in central Taiwan. J Microbiol Immunol Infect 2000; 33(4):233–236.
   PubMedGoogle Scholar
• Crameri R. High throughput screening: A rapid way to recombinant allergens. Allergy 2001; 56(Suppl 67):30–34.
   PubMed Web of Science ®Google Scholar
• Thomas WR. The advent of recombinant allergens and allergen cloning. J Allergy Clin Immunol 2011; 127(4):855–859.
   PubMed Web of Science ®Google Scholar
• Puggioni F, Durham SR, Francis JN. Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses. Allergy 2005; 60(5):678–684.
   PubMed Web of Science ®Google Scholar
• Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 2006; 367(9518):1247–1255.
   PubMed Web of Science ®Google Scholar
• Qureshi N, Takayama K, Ribi E. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J Biol Chem 1982; 257(19):11808–11815.
   PubMed Web of Science ®Google Scholar
• Thompson BS, Chilton PM, Ward JR, Evans JT, Mitchell TC. The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells. J Leukoc Biol 2005; 78(6):1273–1280.
   PubMed Web of Science ®Google Scholar
• Okemoto K, Kawasaki K, Hanada K, Miura M, Nishijima M. A potent adjuvant monophosphoryl lipid A triggers various immune responses, but not secretion of IL-1beta or activation of caspase-1. J Immunol 2006; 176(2):1203–1208.
   PubMed Web of Science ®Google Scholar
• Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007; 316(5831):1628–1632.
   PubMed Web of Science ®Google Scholar
• Cekic C, Casella CR, Eaves CA, Matsuzawa A, Ichijo H, Mitchell TC. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J Biol Chem 2009; 284(46):31982–31991.
   PubMed Web of Science ®Google Scholar
• Wu CJ, Chen LC, Kuo ML. Attenuated Salmonella typhimurium reduces ovalbumin-induced airway inflammation and T-helper type 2 responses in mice. Clin Exp Immunol 2006; 145(1):116–122.
   PubMed Web of Science ®Google Scholar
• Anderson RC, Fox CB, Dutill TS, Shaverdian N, Evers TL, Poshusta GR, Chesko J, Coler RN, Friede M, Reed SG, Vedvick TS. Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations. Colloids Surf B Biointerfaces 2010; 75(1):123–132.
   PubMed Web of Science ®Google Scholar
• de Vries JE, Gauchat JF, Aversa GG, Punnonen J, Gascan H, Yssel H. Regulation of IgE synthesis by cytokines. Curr Opin Immunol 1991; 3(6):851–858.
   PubMed Web of Science ®Google Scholar
• Moreira LO, Smith AM, DeFreitas AA, Qualls JE, El Kasmi KC, Murray PJ. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2. Vaccine 2008; 26(46):5808–5813.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol 2010; 11(5):373–384.
   PubMed Web of Science ®Google Scholar
• Bortolatto J, Borducchi E, Rodriguez D, Keller AC, Faquim-Mauro E, Bortoluci KR, Mucida D, Gomes E, Christ A, Schnyder-Candrian S, Schnyder B, Ryffel B, Russo M. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: Role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis. Clin Exp Allergy 2008; 38(10):1668–1679.
   PubMed Web of Science ®Google Scholar
• Focke M, Swoboda I, Marth K, Valenta R. Developments in allergen-specific immunotherapy: From allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin Exp Allergy 2010; 40(3):385–397.
   PubMed Web of Science ®Google Scholar
• Scadding G, Durham S. Mechanisms of sublingual immunotherapy. J Asthma 2009; 46(4):322–334.
   PubMed Web of Science ®Google Scholar
• Wachholz PA, Durham SR. Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol 2004; 4(4):313–318.
   PubMed Web of Science ®Google Scholar
• Takai T, Yokota T, Yasue M, Nishiyama C, Yuuki T, Mori A, Okudaira H, Okumura Y. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nat Biotechnol 1997; 15(8):754–758.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rioja R, Ibarrola I, Arilla MC, Ferrer A, Mir A, Andreu C, Martinez A, Asturias JA. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy. J Allergy Clin Immunol 2007; 120(3):602–609.
   PubMed Web of Science ®Google Scholar
• Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ. A navigator for human genome epidemiology. Nat Genet 2008; 40(2):124–125.
   PubMed Web of Science ®Google Scholar
• Vercelli D. Gene-environment interactions in asthma and allergy: The end of the beginning?. Curr Opin Allergy Clin Immunol 2010; 10(2):145–148.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Qian FH, Zhou LF, Wei GZ, Jin GF, Bai JL, Yin KS. Polymorphisms in Toll-like receptor 4 gene are associated with asthma severity but not susceptibility in a Chinese Han population. J Investig Allergol Clin Immunol 2011; 21(5):370–377.
   PubMed Web of Science ®Google Scholar
• Platts-Mills JA, Custis NJ, Woodfolk JA, Platts-Mills TA. Airborne endotoxin in homes with domestic animals: Implications for cat-specific tolerance. J Allergy Clin Immunol 2005; 116(2):384–389.
   PubMed Web of Science ®Google Scholar
• Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, Maisch S, Carr D, Gerlach F, Bufe A, Lauener RP, Schierl R, Renz H, Nowak D, von Mutius E. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347(12):869–877.
   PubMed Web of Science ®Google Scholar
• Dong L, Li H, Wang S, Li Y. Different doses of lipopolysaccharides regulate the lung inflammation of asthmatic mice via TLR4 pathway in alveolar macrophages. J Asthma 2009; 46(3):229–233.
   PubMed Web of Science ®Google Scholar
• Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25(2):187–191.
   PubMed Web of Science ®Google Scholar
• Werner M, Topp R, Wimmer K, Richter K, Bischof W, Wjst M, Heinrich J. TLR4 gene variants modify endotoxin effects on asthma. J Allergy Clin Immunol 2003; 112(2):323–330.
   PubMed Web of Science ®Google Scholar
• Baldridge JR, McGowan P, Evans JT, Cluff C, Mossman S, Johnson D, Persing D. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther 2004; 4(7):1129–1138.
   PubMed Web of Science ®Google Scholar